Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/2TG stock hub

FRA/2TG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/2TGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/2TG

In the news

Latest news · FRA/2TG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E28.7

P25 n/aP50 n/aP75 n/a

ROE10.5

P25 n/aP50 n/aP75 n/a

ROIC9.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/2TG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Ireland
Country code	DE
Employees	17,787
Employees Change	-392%
Employees Change Percent	-2.16
Enterprise value	EUR 18.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	EUR 17.3B
Price	EUR 194
Price currency	EUR
Rev Per Employee	279,064.51x
Sic	3841
Symbol	fra/2TG
Website	https://www.steris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.49%
EV Earnings	30.99x
EV/EBIT	20.2x
EV/EBITDA	13.37x
EV/FCF	23.92x
EV/Sales	3.77x
FCF yield	4.52%
Forward P/E	19.13x
P/B ratio	2.83x
P/E ratio	28.68x
P/S ratio	3.48x
PE Ratio10 Y	52.68x
PE Ratio3 Y	66.32x
PE Ratio5 Y	68.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.68%
EBITDA Margin	27.02%
FCF margin	15.74%
Gross margin	44.32%
Gross Profit	EUR 2.2B
Gross Profit Growth	9.22%
Gross Profit Growth Q	7.34%
Gross Profit Growth3 Y	6.38%
Gross Profit Growth5 Y	14.19%
Net Income	EUR 602.8M
Net Income Growth	51.35%
Net Income Growth Q	11.18%
Net Income Growth5 Y	10.31%
Pretax Margin	16.13%
Profit Margin	12.14%
Profit Per Employee	EUR 33,889
ROA	6.61
Roa5y	5.27
ROCE	11.26
ROE	10.47
Roe5y	8.7
ROIC	9.39
Roic5y	7.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Div CAGR10	9.89%
Div CAGR3	8.56%
Div CAGR5	11.31%
EPS Growth	51.78
EPS Growth Q	12.07
EPS Growth5 Y	7.24
FCF Growth	22.05%
FCF Growth Q	-18.1%
FCF Growth3 Y	37.96%
FCF Growth5 Y	14.03%
OCF Growth	10.92%
OCF Growth Q	-10.4%
OCF Growth10 Y	21.18%
OCF Growth3 Y	21.12%
OCF Growth5 Y	12.56%
Revenue Growth	7.96x
Revenue Growth Q	9.16x
Revenue Growth3 Y	6.8x
Revenue Growth5 Y	13.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.57
Assets	EUR 9B
Cash	EUR 360.9M
Current Assets	EUR 1.9B
Current Liabilities	EUR 782.1M
Debt	EUR 1.7B
Debt EBITDA	EUR 1.25
Debt Equity	EUR 0.29
Debt FCF	EUR 2.24
Equity	EUR 6.1B
Interest Coverage	17.35
Liabilities	EUR 2.9B
Long Term Assets	EUR 7.1B
Long Term Liabilities	EUR 2.1B
Net Cash	EUR -1.4B
Net Cash By Market Cap	EUR -8.03
Net Debt EBITDA	EUR 1.04
Net Debt Equity	EUR 0.23
Net Debt FCF	EUR 1.78
Tangible Book Value	EUR 1B
Tangible Book Value Per Share	EUR 10.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.48
Inventory Turnover	4.91
Net Working Capital	EUR 830.1M
Quick ratio	1.53
Working Capital	EUR 1.2B
Working Capital Turnover	EUR 4.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.49%
Dividend Growth	3.64%
Dividend Growth Years	15%
Dividend per share	EUR 2.27
Dividend Years	22
Dividend Yield	1.18%
Ex Div Date	2026-02-17
Last Dividend	EUR 0.53
Payout Frequency	Quarterly
Payout Ratio	33.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	190.9
All Time High	232
All Time High Change	-16.59%
All Time High Date	2025-11-06
All Time Low	172.8
All Time Low Change	11.98%
All Time Low Date	2026-04-30
ATR	8.19
Ch YTD	-9.58
High	193.5
High52	232
High52 Date	2025-11-06
High52ch	-16.59%
Low	173.6
Low52	172.8
Low52 Date	2026-04-30
Low52ch	11.98%
Ma50ch	1.36%
RSI	37.1
RSI Monthly	0
RSI Weekly	31.72
Sharpe ratio	-1.03x
Sortino ratio	-1.21
Total Return	1.67%
Tr YTD	-9.34
Tr1m	2.33%
Tr1w	6.61%
Tr3m	-8.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 927.2M
Operating Income Growth	13.56
Operating Income Growth Q	10.11
Operating Income Growth3 Y	16.73
Operating Income Growth5 Y	13.35
Operating margin	18.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,694,370%
Net Borrowing	-243,474,481.1
Shares Insiders	0.3%
Shares Institutions	96.23%
Shares Qo Q	-0.2%
Shares Yo Y	-0.49%
Short Ratio	2.03

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 731.2M
Average Volume	6.1x
Bv Per Share	62.12
CAPEX	EUR -297.8M
Ch1m	2.33
Ch1w	6.61
Ch3m	-8.73
Ch6m	-14.38
Change	11.33%
Change From Open	11.46
Close	173.8
Days Gap	-0.12
Depreciation Amortization	412,291,843.8
Earnings Date	2026-05-11
EBIT	EUR 927.2M
EBITDA	EUR 1.3B
EPS	EUR 6.1
F Score	8
FCF	EUR 781.1M
FCF EV Yield	4.18x
Financing CF	-552,211,619
Fiscal Year End	March
Founded	1,985
Goodwill	3,588,575,184
Graham Number	101.86046
Graham Upside	-47.36
Income Tax	EUR 194.6M
Investing CF	-310,978,666
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Lynch Fair Value	EUR 69.56
Lynch Upside	-64.05
Ma150	206.9
Ma150ch	-6.46%
Ma20	185.2
Ma20ch	4.47%
Net CF	228,665,268
Next Earnings Date	2026-05-11
Open	173.6
P FCF Ratio	22.13
P OCF Ratio	16.02
Payment Date	2026-03-19
Position In Range	100
Ppne	1,940,221,852.2
Price Date	2026-05-08
Price EBITDA	EUR 12.89
Ptbv Ratio	16.49
Relative Volume	4.29x
Revenue	4,963,720,376x
SBC By Revenue	1.01x
Share Based Comp	49,907,065
Tax By Revenue	3.92x
Tax Rate	24.3%
Tr6m	-13.94%
Volume	0
Z Score	5.49

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/2TG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$2.27 annual per share

Payout ratio

+33.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.3%

15 consecutive years of growth

Total shareholder yield

+1.7%

Next ex-dividend date: 2026-02-17

Ownership

Who owns FRA/2TG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+96.2%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/2TG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/2TG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2TG stock rating?

fra/2TG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2TG analysis?

The full report lives at /stocks/fra/2TG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2TG?

The latest report frames fra/2TG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2TG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.